Cancer Research UK and HSBC join forces in USD25 million partnership
Cancer Research UK today announced a partnership with HSBC to support the scientific leaders of tomorrow through a contribution of USD25 million towards the development of the Francis Crick Institute. The new state-of-the-art biomedical research facility is currently being built in King’s Cross, in the heart of London. HSBC’s support is contributing to the cost of the construction of the Francis Crick Institute which is due to open in 2016.
Cancer Research UK will receive USD5 million per year from HSBC for the next five years (2015-2019).
The Francis Crick Institute will see more than 1,200 scientists, representing a variety of disciplines, collaborating to tackle the diseases that pose the greatest threat to humanity – cancer, heart disease, lung disease, infectious diseases such as HIV and malaria and many more.
The collaboration between HSBC, Cancer Research UK and the Francis Crick Institute will be marked by 150 PhD students who will be provided with an opportunity to conduct vital research at the new institute. The young scientists will be selected from across the world for the PhD programme.
Harpal Kumar, Chief Executive Officer at Cancer Research UK, said: “Cancer Research UK has a long history of working with HSBC, but this donation really is game-changing for us. This extraordinarily generous gift will cement our commitment to investing in the highest quality science by helping us to support some of the best and most imaginative scientists in the world.”
HSBC’s donation is part of a series of community investments being made globally to mark HSBC’s 150th anniversary. Overall USD150 million of additional funding has been committed to community projects over three years (2015-2017) around the world.
Douglas Flint, HSBC Group Chairman, said: “We are very proud to support the 150 PhD students at the Francis Crick Institute. In working with the team at Cancer Research UK, it became clear that the Crick would be an environment where the best and brightest talent from all over the world would come together in new fields of research, to make ground breaking progress in the fight against some of the most urgent health and disease issues. We hope our PhD students will be the future leaders in their field and wish them all the best in their vital work at the Crick.”
For more information, please contact Jenna Coles in the Cancer Research UK press office – firstname.lastname@example.org / 0207 469 8076
For HSBC media enquiries, please contact Gillian James in the HSBC Corporate press office at email@example.com / 020 7992 0516
Notes to editors
About The Francis Crick Institute*
The Francis Crick Institute is a world-leading centre of biomedical research and innovation. It will house 1,200 leading scientists from a variety of disciplines working together under one roof to tackle the biggest health challenges faced by humankind. Dedicated to research excellence, the institute will have the scale, vision and expertise to tackle challenging scientific questions underpinning health and disease.
Due for completion in 2016, The Francis Crick Institute is a visionary collaboration between six of the world’s leading medical research organisations: Cancer Research UK, the Medical Research Council, the Wellcome Trust, UCL (University College London), King’s College London and Imperial College London. It will be world-class with a strong national role – training scientists and developing ideas for public good. www.crick.ac.uk
*Please refer to the institute as the Francis Crick Institute initially in all copy. It can be referred to as the Crick after the first mention.
About Cancer Research UK
- Cancer Research UK is the world’s leading cancer charity dedicated to saving lives through research
- Cancer Research UK’s pioneering work into the prevention, diagnosis and treatment of cancer has helped save millions of lives
- Cancer Research UK receives no government funding for its life-saving research. Every step it makes towards beating cancer relies on every pound donated
- Cancer Research UK has been at the heart of the progress that has already seen survival rates in the UK double in the last forty years
- Today, 2 in 4 people survive cancer. Cancer Research UK’s ambition is to accelerate progress so that 3 in 4 people will survive cancer within the next 20 years
- Cancer Research UK supports research into all aspects of cancer through the work of over 4,000 scientists, doctors and nurses
- Together with its partners and supporters, Cancer Research UK’s vision is to bring forward the day when all cancers are cured
For further information about Cancer Research UK’s work or to find out how to support the charity, please call 0300 123 1022 or visit www.cancerresearchuk.org (opens in new window). Follow us on Twitter and Facebook.
The HSBC Group
HSBC Holdings plc, the parent company of the HSBC Group, is headquartered in London. The Group serves customers worldwide from over 6,100 offices in 72 countries and territories in Asia, Europe, North and Latin America, and the Middle East and North Africa. With assets of US$2,572bn at 30 June 2015, HSBC is one of the world’s largest banking and financial services organisations.
HSBC’s US$150m community fund
HSBC marks its 150th anniversary in 2015. As part of this, HSBC has committed an additional USD150m fund to community projects over three years (2015-2017). More than 140 charities worldwide have been selected by HSBC’s management team, based on votes from HSBC employees for charitable themes. The USD150m fund is in addition to the USD114m HSBC makes available to community investment programmes globally each year.
Climate in the COVID era
As COVID-19 sharpens investors’ focus on environmental, social and governance issues, we highlight six developments to watch.
Making the USD10 trillion case for trade
A new report co-written by HSBC demonstrates trade’s critical role in the recovery from COVID-19.
Pandemic hastens digital economy
COVID-19 has accelerated a switch to online living. What could it mean for societies worldwide?